Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 267-051-0
CAS number: 67774-74-7
No clinical signs were observed during the
A single intravenous dose of test substance
was given to 5 male and 5 female rats. Samples of urine and faeces were
taken at pre-dose, 0.5, 4, 8, 24, 72, and 96 hrs post-dose. Whole body
autoradiography was done for 1 animal of each sex at 0.5, 4, 8, 24, and
96 hrs after dosing. No clinical signs were observed during the study.
The test substance was rapidly eliminated from the majority of tissues,
though some remained in fatty tissues. Metabolism of the test substance
was rapid, and it was eliminated mostly through the urine.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Niniejsza strona używa plików cookies, aby zapewnić optymalne korzystanie z naszych stron internetowych.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again